Sex matters: Systemic complement activity of female C57BL/6J and BALB/cJ mice is limited by serum terminal pathway components

Molecular Immunology

Volumn 76, Issue , 2016, Pages 13-21

  Kotimaa, Juha ^a   Klar Mohammad, Ngaisah ^a   Gueler, Faikah ^b   Schilders, Geurt ^c   Jansen, Aswin ^c   Rutjes, Helma ^c,d   Daha, Mohamed R ^a   van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Hycult Biotech   (Netherlands)

^d Pivot Park Screening Centre   (Netherlands)

Author keywords

Alternative pathway; C6; C9; Classical pathway; Complement system; Lectin pathway; Mouse gender dimorphism; Terminal pathway

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT COMPONENT C6;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD-1 MOUSE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; FEMALE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; ANIMAL; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; SEXUAL DEVELOPMENT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C6; COMPLEMENT C9; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SEX CHARACTERISTICS;

EID: 84975482501     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2016.06.004     Document Type: Article

References (42)

1. Angele M.K., Pratschke S., Hubbard W.J., Chaudry I.H. Gender differences in sepsis: cardiovascular and immunological aspects. Virulence 2014, 5:12-19. 10.4161/viru.26982.
2. Asgari E., Farrar C.A., Lynch N., Ali Y.M., Roscher S., Stover C., Zhou W., Schwaeble W.J., Sacks S.H. Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4. FASEB J. 2014, 10.1096/fj.13-246306.
3. Ashman R.B., Kay P.H., Lynch D.M., Papadimitriou J.M. Murine candidiasis: sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5. Immunol. Cell Biol. 1991, 69(Pt 1):7-10. 10.1038/icb.1991.2.
4. Aufhauser D.D., Wang Z., Murken D.R., Bhatti T.R., Wang Y., Ge G., Redfield R.R., Abt P.L., Wang L., Svoronos N., Thomasson A., Reese P.P., Hancock W.W., Levine M.H. Improved renal ischemia tolerance in females influences kidney transplantation outcomes. J. Clin. Invest. 2016, 126:1968-1977. 10.1172/JCI84712.
5. Baba a, Fujita T., Tamura N. Sexual dimorphism of the fifth component of mouse complement. J. Exp. Med. 1984, 160:411-419. 10.1084/jem.160.2.411.
6. Beurskens F., Aerts P., Robins D.M., van Dijk H. Sex-limited protein: in-vitro and in-vivo functions. Mol. Immunol. 1998, 35:356. 10.1016/S0161-5890(98)90636-8.
7. Buras J.A., Rice L., Orlow D., Pavlides S., Reenstra W.R., Ceonzo K., Stahl G.L. Inhibition of C5 or absence of C6 protects from sepsis mortality. Immunobiology 2004, 209:629-635. 10.1016/j.imbio.2004.09.004.
8. Chen P.-D., Tsai M.-K., Lee C.-Y., Yang C.-Y., Hu R.-H., Lee P.-H., Lai H.-S. Gender differences in renal transplant graft survival. J. Formos. Med. Assoc. 2013, 112:783-788. 10.1016/j.jfma.2013.10.011.
9. Churchill W.H., Weintraub R.M., Borsos T., Rapp H.J. Mouse complement: the effect of sex hormones and castration on two of the late-acting components. J. Exp. Med. 1967, 125:657-672. 10.1084/jem.125.4.657.
10. Cinander B., Dubiski S., Wardlaw a.C. Distribution, inheritance, and properties of an antigen, MUB1, and its relation to hemolytic complement. J. Exp. Med. 1964, 120:897-924.
11. de Vries B., Köhl J., Leclercq W.K.G., Wolfs T.G.a.M., van Bijnen A.a.J.H.M., a J.H.M., Heeringa P., Buurman W.a. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 2003, 170:3883-3889. 10.4049/jimmunol.170.7.3883.
12. de Vries B., Walter S.J., Peutz-Kootstra C.J., Wolfs T.G.a.M, van Heurn L.W.E., Buurman W.a. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am. J. Pathol. 2004, 165:1677-1688. 10.1016/S0002-9440(10)63424-4.
13. Fukuoka Y., Seino J., Okuda T., Tachibana T. Development of a hemolytic assay for mouse complement components in sera and the variation of their levels with age. Tohoku J. Exp. Med. 1982, 137:79-90. 10.1620/tjem.137.79.
14. Hewitt C.R.a. C3d complements immunity. Mol. Med. Today 1996, 2:96-97. 10.1016/1357-4310(96)88715-6.
15. Holt D.S., Botto M., Bygrave A.E., Melanie Hanna S., Walport M.J., Paul Morgan B. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 2001, 98:442-449. 10.1182/blood.V98.2.442.
16. Hu H., Wang G., Batteux F., Nicco C. Gender differences in the susceptibility to renal ischemia-reperfusion injury in BALB/c mice. Tohoku J. Exp. Med. 2009, 218:325-329. 10.1620/tjem.218.325.
17. Kang K.P., Lee J.E., Lee A.S., Jung Y.J., Kim D., Lee S., Hwang H.P., Kim W., Park S.K. Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice. Mol. Med. Rep. 2014, 9:2061-2068. 10.3892/mmr.2014.2089.
18. Kotimaa J., van der Pol P., Leijtens S., Klar-Mohammad N., Schilders G., Daha M.R., Rutjes H., van Kooten C. Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia/reperfusion injury. J. Immunol. Methods 2014, 412:14-23. 10.1016/j.jim.2014.06.011.
19. Kotimaa J.P., van Werkhoven M.B., O'Flynn J., Klar-Mohamad N., van Groningen J., Schilders G., Rutjes H., Daha M.R., Seelen M.A., van Kooten C. Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury. J. Immunol. Methods 2015, 419:25-34. 10.1016/j.jim.2015.02.010.
20. Locke J.E., Magro C.M., Singer a.L.., Segev D.L., Haas M., Hillel a.T., King K.E., Kraus E., Lees L.M., Melancon J.K., Stewart Z.a., Warren D.S., Zachary a.a., Montgomery R.a. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am. J. Transplant. 2009, 9:231-235. 10.1111/j.1600-6143.2008.02451.x.
21. Mastellos D., Prechl J.O., László G., Papp K., Oláh E., Argyropoulos E., Franchini S., Tudoran R., Markiewski M., Lambris J.D., Erdei A. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol. Immunol. 2004, 40:1213-1221. 10.1016/j.molimm.2003.10.019.
22. Miwa T., Sato S., Gullipalli D., Nangaku M., Song W.-C. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-Reperfusion injury in decay-accelerating factor and CD59 double-knockout mice. J. Immunol. 2013, 190:3552-3559. 10.4049/jimmunol.1202275.
23. Morgan B.P., Harris C.L. Complement, a target for therapy in inflammatory and degenerative diseases. Nat. Rev. Drug Discov. 2015, 14:857-877. 10.1038/nrd4657.
24. Natsuume-Sakai S., Motonishi K., Takahashi M. Quantitation of beta 1c/1A globulin (C3) in inbred mice: variation dependent upon strain, age, sex and environment. Int. Arch. Allergy Appl. Immunol. 1977, 53:269-278. 10.1159/000231762.
25. Nauta A.J., Roos A., Daha M.R. A regulatory role for complement in innate immunity and autoimmunity. Int. Arch. Allergy Immunol. 2004, 134:310-323. 10.1159/000079261.
26. Ong G.L., Mattes M.J. Mouse strains with typical mammalian levels of complement activity. J. Immunol. Methods 1989, 125:147-158. 10.1016/0022-1759(89)90088-4.
27. Ong G.L., Baker a.E.M., Mattes M.J. Analysis of high complement levels in Mus hortulanus and BUB mice. J. Immunol. Methods 1992, 154:37-45. 10.1016/0022-1759(92)90210-K.
28. Osmers I., Szalai A.J., Tenner A.J., Barnum S.R. Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated. Mol. Immunol. 2006, 43:1722-1725. 10.1016/j.molimm.2005.10.004.
29. Otten M.a, Groeneveld T.W.L., Flierman R., Rastaldi M.P., Trouw L.a, Faber-Krol M.C., Visser A., Essers M.C., Claassens J., Verbeek J.S., van Kooten C., Roos A., Daha M.R. Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice. J. Immunol. 2009, 183:3980-3988. 10.4049/jimmunol.0901301.
30. Peng Q., Li K., Anderson K., Farrar C.a., Lu B., Smith R.a.G., Sacks S.H., Zhou W. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008, 111:2452-2461. 10.1182/blood-2007-06-095018.
31. Peng Q., Li K., Sacks S.H., Zhou W. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm. Allergy Drug Targets 2009, 8:236-246. 10.2174/187152809788681038.
32. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797. 10.1038/ni.1923.
33. Ronchi J.A., Figueira T.R., Ravagnani F.G., Oliveira H.C.F., Vercesi A.E., Castilho R.F. A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities. Free Radic. Biol. Med. 2013, 63:446-456. 10.1016/j.freeradbiomed.2013.05.049.
34. Roos A., Bouwman L.H., Munoz J., Zuiverloon T., Faber-Krol M.C., Fallaux-van den Houten F.C., Klar-Mohamad N., Hack C.E., Tilanus M.G., Daha M.R. Functional characterization of the lectin pathway of complement in human serum. Mol. Immunol. 2003, 39:655-668. 10.1016/S0161-5890(02)00254-7.
35. Strait R.T., Hicks W., Barasa N., Mahler a., Khodoun M., Kohl J., Stringer K., Witte D., Van Rooijen N., Susskind B.M., Finkelman F.D. MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J. Exp. Med. 2011, 208:2525-2544. 10.1084/jem.20110159.
36. Tanaka S., Suzuki T., Nishioka K. Assay of classical and alternative pathway activities of murine complement using antibody-sensitized rabbit erythrocytes. J. Immunol. Methods 1986, 86:161-170. 10.1016/0022-1759(86)90448-5.
37. Trouw L.a., Seelen M.a., Duijs J.M.G.J., Benediktsson H., Van Kooten C., Daha M.R. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin. Exp. Immunol 2003, 132:32-39. 10.1046/j.1365-2249.2003.02108.x.
38. Trouw L.a., Groeneveld T.W.L., Seelen M.a., Duijs J.M.G.J., Bajema I.M., Prins F.a., Kishore U., Salant D.J., Verbeek J.S., Van Kooten C., Daha M.R. Anti C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 2004, 114:679-688. 10.1172/JCI200421075.
39. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066. 10.1056/NEJM200104053441406.
40. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144. 10.1056/NEJM200104123441506.
41. Ward P.a. The harmful role of C5a on innate immunity in sepsis. J. Innate Immun. 2010, 2:439-445. 10.1159/000317194.
42. Zhou W., Farrar C.a., Abe K., Pratt J.R., Marsh J.E., Wang Y., Stahl G.L., Sacks S.H. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 2000, 105:1363-1371. 10.1172/JCI8621.